SCHEMBL9301153

SCHEMBL9301153

Cc1cc(C(=O)NC(C)(C)C)ccc1Br

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA1 P02708 1/20 0.59
CHRNG P07510 1/20 0.59
CHRNB1 P11230 1/20 0.59
CHRNB2 P17787 1/20 0.59
SLC6A2 P23975 1/20 0.59
CHRNB4 P30926 1/20 0.59
SLC6A4 P31645 1/20 0.59
CHRNA3 P32297 1/20 0.59
CHRNA4 P43681 1/20 0.59
SLC6A3 Q01959 1/20 0.59
CHRND Q07001 1/20 0.59
RAB9A P51151 3/20 0.46
MAPT P10636 2/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX12 P18054 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25385568 0.84 NPC1 (0.53) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL14867646 0.84 KMT2A (0.51) RAB9AMAPTALDH1A1MEN1KMT2A
SCHEMBL12553737 0.83 MAPT (0.46) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL5601531 0.82 HDAC6 (0.59) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL27007874 0.82 CHRNA1 (0.53) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL6423147 0.81 POLB (0.48) RAB9AMAPTALDH1A1CYP2C19MEN1
SCHEMBL16823591 0.81 MAPT (0.53) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL8507005 0.80 HDAC6 (0.53) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL30107275 0.80 HDAC6 (0.53) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL1933083 0.79 ALDH1A1 (0.59) RAB9AMAPTALDH1A1CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5356893-A Antidepressants, nervous system disorders GLAXO GROUP LIMITED (GB) 1994-10-18 US disclosed
EP-0533266-A1 Benzanilide derivatives as 5-HT1D antagonists GLAXO GROUP LIMITED (GB) 1993-03-24 EP disclosed